Better Business Bureau
BBB develops the MARK-B™, an automated blood testing device that utilizes Magnetic Electrochemical Sandwich ImmunoAssay (MESIA) technology to deliver lab-quality results from whole blood samples in minutes. This system eliminates the need for pre-processing and simplifies the diagnostic process, enabling users to perform accurate tests for various health conditions in a home setting.
- Biotechnology
- Hardware
- Healthcare Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Traditional blood testing methods often require samples to be sent to a central lab for processing, resulting in delays and increased costs. This can be particularly challenging in point-of-care settings or for patients who require frequent monitoring. Current point-of-care solutions often lack the accuracy and comprehensive test menus of central lab testing.
Solution
BBB develops the MARK-B™, an automated blood testing device that delivers lab-quality results from whole blood samples in minutes using a patented Magnetic Electrochemical Sandwich ImmunoAssay (MESIA) technology. The system eliminates the need for manual pre-processing steps such as centrifugation by automatically separating plasma from whole blood within the self-contained consumable. The electrochemical analysis process then quantifies target analytes with high precision. The MARK-B™ system aims to simplify the diagnostic process and enable rapid, accurate testing for a variety of health conditions at the point of care.
Target Audience
The primary target audience includes healthcare providers in point-of-care settings, clinics, and hospitals seeking rapid and accurate blood testing solutions, as well as researchers and diagnostic companies.
Features
- Utilizes Magnetic Electrochemical Sandwich ImmunoAssay (MESIA) technology for precise quantification of analytes.
- Processes whole blood samples directly, eliminating the need for pre-processing or manual sample preparation.
- Offers a test portfolio including Tumor markers (AFP, PSA, CEA, CA19-9, CA125), Cardiovascular disease markers (cTnI, CK-MB, Myoglobin, D-dimer, hsCRP, NT-proBNP, Galectin-3, ST2), Sepsis markers (PCT, IL-6, CRP), Infectious diseases (COVID-19, Influenza A&B), Thyroid (TSH, T3, T4), Metabolism (Vitamin D, Ferritin), and Alzheimer's disease markers (β-amyloid, τ protein, NfL).
- Connects to a cloud server for seamless communication of test results.
- Supports POCT1-A2 protocol, HL7, and FHIR® for integration with DMS.
- Features a 5.5” HD touch screen display and Android 7.0 operating system.
- Offers wireless connectivity via Wi-Fi 2.4GHz (IEEE802.11 b/g/n) and Bluetooth 4.0 for thermal printer connectivity.
- Provides multiple USB ports for accessories and data transfer.